PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 13, 2010AIDS399 citations

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

View Full Paper
ASArd van SighemStichting HIV MonitoringLGLuuk GrasEuropean Society for Blood and Marrow Transplantation
Peter Reiss
Peter ReissNetherlands Center for Occupational Diseases

Key Points

Key points are not available for this paper at this time.

Abstract

OBJECTIVE: To compare life expectancies between recently diagnosed HIV-infected patients and age and sex-matched uninfected individuals from the general population. DESIGN: : National observational HIV cohort in the Netherlands. METHODS: Four thousand, six hundred and twelve patients diagnosed with HIV between 1998 and 2007 and still antiretroviral therapy-naive as of 24 weeks after diagnosis were selected. Progression to death compared to the age and sex-matched general population was studied with a multivariate hazards model in 4174 (90.5%) patients without AIDS events at 24 weeks. Life expectancy and number of life years lost were calculated using the predicted survival distribution. RESULTS: During 17 580 person-years of follow-up since 24 weeks after diagnosis median follow-up 3.3 years, interquartile range (IQR) 1.6-5.8, 118 deaths occurred, yielding a mortality rate of 6.7 95% confidence interval (CI) 5.5-8.0 per 1000 person-years. Median CD4 cell counts at 24 weeks were 480 cells/microl (IQR 360-650). According to the model, the median number of years lived from age 25 was 52.7 (IQR 44.2-59.3; general population 53.1) for men and 57.8 (49.2-63.7; 58.1) for women without CDC-B event. The number of life years lost varied between 0.4 if diagnosed with HIV at age 25 and 1.4 if diagnosed at age 55; for patients with a CDC-B event this range was 1.8-8.0 years. CONCLUSION: The life expectancy of asymptomatic HIV-infected patients who are still treatment-naive and have not experienced a CDC-B or C event at 24 weeks after diagnosis approaches that of non-infected individuals. However, follow-up time is short compared to the expected number of years lived.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sighem et al. (2010) studied this question.

synapsesocial.com/papers/6a19a2e54b45427442ea80a2https://doi.org/10.1097/qad.0b013e32833a3946
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mortality in Patients With Successful Initial Response to Highly Active Antiretroviral Therapy Is Still Higher Than in Non-HIV-Infected Individuals2005 · 61 citations
  2. 2Aging and Infectious Diseases: Workshop on HIV Infection and Aging: What Is Known and Future Research Directions2008 · 541 citations
  3. 3The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study.2002 · 438 citations
  4. 4Correlates of Lending Needles/Syringes Among HIV-Seropositive Injection Drug Users2007 · 159 citations
  5. 5Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population2008 · 492 citations